Release Date: 28/02/22 18:26 Summary: 1H2022 Results Announcement Price Sensitive: Yes Download Document 333.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%